Liou Harris, Long Jeremiah, Kransdorf Mark, Schmieder Stephanie
Mayo Clinic Alix School of Medicine, 13400 E. Shea Blvd., Scottsdale, AZ, 85259, USA.
Mayo Clinic Arizona, 5777 East Mayo Clinic Blvd, Phoenix, AZ, 85054, USA.
Eur Radiol. 2023 Jun;33(6):3956-3960. doi: 10.1007/s00330-023-09497-0. Epub 2023 Mar 14.
To describe the technique, efficacy, and safety of CT-guided quadratus femoris injection with corticosteroid and local anesthetic for the treatment of ischiofemoral impingement in a series of cases at our institution.
Cases of CT-guided quadratus femoris injections from 2000 to 2021 were identified in the enterprise-wide electronic medical record of our institution. Patient charts and our institutional picture archiving and communication system (PACS) were searched for demographics, pain level on a 0-10 scale before and immediately following the procedure, procedure technique, and follow-up outcomes if available.
There were 13 cases among 12 patients with clinical and imaging findings of ischiofemoral impingement included in this study. Of the 12 patients, 10 were female and two were male. There were eight posterior approaches and five posterolateral approaches. Of the 13 cases, 11 resulted in immediate pain reduction. The median reduction in pain score was four (average 3.46, range 0-8.5). There was no statistically significant difference in pain reduction between the posterior approach cases and the posterolateral approach cases. No cases reported immediate complications or increases in pain score. Of the 12 cases, seven resulted in at least 1 month of pain relief, three had subsequent surgeries, and three had no follow-up.
CT-guided quadratus femoris injection is safe and effective for treating ischiofemoral impingement. Further and larger scale study is needed to fully delineate differences in technique effectiveness.
• CT-guided quadratus femoris injection is safe and effective for treating ischiofemoral impingement. • We found no statistically significant difference in pain reduction between the posterior approach and the posterolateral approach.
描述在我们机构的一系列病例中,CT引导下股方肌注射皮质类固醇和局部麻醉剂治疗坐骨股骨撞击症的技术、疗效和安全性。
在我们机构的企业级电子病历中识别出2000年至2021年CT引导下股方肌注射的病例。检索患者病历以及我们机构的图像存档与通信系统(PACS),以获取人口统计学信息、术前及术后即刻0至10分的疼痛程度、手术技术以及随访结果(如可用)。
本研究纳入了12例具有坐骨股骨撞击症临床和影像学表现的患者中的13例病例。12例患者中,10例为女性,2例为男性。有8例采用后路入路,5例采用后外侧入路。13例病例中,11例疼痛立即减轻。疼痛评分的中位数降低了4分(平均3.46分,范围0至8.5分)。后路入路病例与后外侧入路病例在疼痛减轻方面无统计学显著差异。没有病例报告即刻并发症或疼痛评分增加。12例病例中,7例疼痛缓解至少1个月,3例随后接受了手术,3例没有随访。
CT引导下股方肌注射治疗坐骨股骨撞击症安全有效。需要进一步开展更大规模的研究以全面阐明技术有效性的差异。
• CT引导下股方肌注射治疗坐骨股骨撞击症安全有效。• 我们发现后路入路与后外侧入路在疼痛减轻方面无统计学显著差异。